A look inside our new lab! This is our commitment to delivering the best in medication monitoring. Through our cutting-edge research and development, Aegis is uniquely equipped to keep pace with the ever-changing drug landscape in support of our mission of helping clinicians make better decisions.
Aegis Sciences Corporation
Hospitals and Health Care
Nashville, TN 16,781 followers
Helping Clinicians Make Better Decisions
About us
Founded in 1990, Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory that provides science-driven drug testing and consulting services based in Nashville, TN. Aegis delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions through definitive testing of urine, oral fluid, or blood specimens. Aegis healthcare testing services are designed for the unique needs of healthcare specialties in the areas of Pain Management, Behavioral and Mental Health, Substance Use Disorder, Prenatal and Chronic Disease Management. Aegis provides clarity for enhanced patient care to a wide array of clinicians that serve Medicare, Managed Medicaid, Commercially Insured and Workers' compensation populations. In addition to healthcare testing services, Aegis offers anti-doping and forensic testing services to professional and amateur sports organizations, college and university athletic programs. Aegis’s biopharma lab provides molecular diagnostic services, including clinical trial services, pharmacogenetic testing, and other services. For more information please visit http://www.aegislabs.com/.
- Website
-
http://www.aegislabs.com
External link for Aegis Sciences Corporation
- Industry
- Hospitals and Health Care
- Company size
- 501-1,000 employees
- Headquarters
- Nashville, TN
- Type
- Privately Held
- Founded
- 1990
- Specialties
- Laboratory, Diagnostics, Medication Adherence, Drug Testing, and Definitive Testing
Locations
-
Primary
515 Great Circle Rd
Nashville, TN 37228, US
Employees at Aegis Sciences Corporation
Updates
-
“Researchers found strong evidence of an association between cannabis use disorder and schizophrenia among men and women, though the association was much stronger among young men.” This is according to a news release from The National Institute on Drug Abuse (NIDA), found here: https://lnkd.in/gD2r5uuH. Managing individuals with substance use disorder (SUD) and mental illness can be complex, and clinicians may benefit from tools to monitor treatment adherence. Definitive testing for marijuana and prescribed psychiatric medications can confirm medication adherence and allow for quantitative measurement of THC levels in urine to monitor elimination and any indications of re-use. Aegis works with SUD and psychiatric clinicians across the country to help inform treatment decisions in the management of individuals experiencing multiple diagnoses. Learn more today: https://lnkd.in/ef6dR7mV #AegisLabs #Cannabis #MentalIllness #Schizophrenia #SubstanceUseDisorder
-
The presence of counterfeit substances containing polysubstances and adulterants continues to vary and grow over time. The general population attempting to use medications recreationally are at an all-time risk of a potentially fatal overdose due to the lethal options available in the illicit drug space. All individuals are at a greater risk of harm when substances are adulterated with multiple compounds. Aegis continues to expand testing to protect the public from unapproved, diverted, or counterfeit drugs presenting overdose risks. Learn more here: https://lnkd.in/g5S-kZXe #AegisLabs #OverdosePrevention #OnePillCanKill #NPS #DrugTesting
Aegis Sciences Corporation Announces Its Adoption of Self-Regulatory Standards for NPS Testing - Aegis Sciences Corporation
https://www.aegislabs.com
-
It is important to remember both illicit and prescription drugs when focusing on drug-related visits to the ED. According to the 2022 report of the Drug Abuse Warning Network (DAWN), prescription or other opioids were reported in 39.4% of opioid-related ED visits and oxycodone was the most common opioid reported (32.9%). Medication compliance is extremely important to monitor when prescribing opioids or any drug that has the potential for abuse/misuse. Read more here: https://lnkd.in/eynGhXFT Aegis offers an expansive menu for both medication adherence and illicit drug use, including IMF (illegally manufactured fentanyl), xylazine, medetomidine, etc., and the most up-to-date and robust menu of novel psychoactive substances. Learn more today: https://lnkd.in/emXVQJ93 #AegisLabs #AegisEducates #IllicitDrugs #OnePillCanKill #NPS
-
Nitazene analogs are novel psychoactive substances which are structurally different from fentanyl but attach to the same mu-opioid receptor. Recent studies have demonstrated that drugs within the nitazene class more often than not have greater potency than illicitly manufactured fentanyl, prescription opioids, and other designer opioids. In Aegis’ testing, increasing co-detection of fentanyl, fentanyl analogs, and nitazene analogs demonstrate that the drug supply is becoming more adulterated. Learn more about nitazene analogs by watching a recently recorded webinar here: https://lnkd.in/ejtCHFuc #AegisLabs #AegisEducates #Nitazenes #Fentanyl #Opioids #OnePillCanKill
New Nitazene Data – Ongoing Evaluation of an Emerging Threat - Aegis Sciences Corporation
https://www.aegislabs.com
-
The illicit drug supply is ever-changing. Illicitly-manufactured fentanyl (IMF) is often found in combination with many substances, including other opioids such as fentanyl analogs and/or nitazene analogs. In many cases, these substances are more potent than fentanyl. Learn more about nitazene analogs by watching this week’s recorded webinar here: https://lnkd.in/ejtCHFuc #AegisLabs #AegisEducates #Nitazenes #NPS #Fentanyl #Opioids #IllicitDrugs #OverdosePrevention #OnePillCanKill #Webinar #Clinical
New Nitazene Data – Ongoing Evaluation of an Emerging Threat - Aegis Sciences Corporation
https://www.aegislabs.com
-
A recent study showed that designer benzodiazepine use was linked to an increase in morbidity and mortality. Tools to discover the use of designer are available, most notably, enhanced drug testing. Read more here: https://lnkd.in/ecj_vWDa Aegis offers clinicians the ability to detect designer benzodiazepine use in their patients, which affords the opportunity to discuss further risk mitigation. Learn more today: https://lnkd.in/emXVQJ93 #AegisLabs #NPS #DesignerDrugs #OnePillCanKill #OverdosePrevention
Fake Xanax: Designer Emerging Benzodiazepine Epidemic Linked to Morbidity and Mortality a Narrative Review - PubMed
pubmed.ncbi.nlm.nih.gov
-
Please join us tomorrow, Tuesday, June 25th, as we will be discussing both previous and recent published finding on nitazenes, as well as, trends in Aegis results related to changes in detection of nitazene analogs over time. Register today: https://lnkd.in/ejtCHFuc #AegisLabs #AegisEducates #Nitazenes #NPS #DesignerOpioids #OnePillCanKill #LivePresentation #Webinar #Education #PublicSafety
-
Please join us on Tuesday, June 25, for an educational webinar hosted by Andrew Holt, PharmD, BCMAS, CPGx, Clinical Pharmacist, Aegis Sciences Corporation. Dr. Holt will discuss new data on Nitazenes, an emerging threat. Register Today: https://lnkd.in/ejtCHFuc #AegisLabs #AegisEducates #Nitazenes #NPS #DesignerOpioids #OnePillCanKill #LivePresentation #Webinar #Education #PublicSafety
New Nitazene Data – Ongoing Evaluation of an Emerging Threat - Aegis Sciences Corporation
https://www.aegislabs.com
-
Nitazene analogs, a class of illicitly-manufactured opioids that are not approved for human use, are known for their high potency and ability to contribute to adverse events, such as overdose deaths. While illicitly-manufactured fentanyl remains the predominant driver of overdoses in the US, peer-reviewed publications and data reported by surveillance organizations continue to indicate that nitazenes are part of an ongoing public health threat. As novel high-potency opioids continue to garner national and international attention, often resulting in regulation as controlled substances, it is possible that we will continue to see new and different drugs emerge. Testing and monitoring are crucial for understanding and mitigating the impact of these substances on public health. Clinical Update: https://lnkd.in/eY-nPcFx #AegisLabs #AegisEducates #Nitazenes #NPS #DesignerOpioids #OnePillCanKill #PublicSafety